In this conversation, Jon Furniss shares his personal journey with Type 1 diabetes, detailing his diagnosis, self-education, and the importance of understanding insulin management. He discusses the impact of lifestyle choices, including diet and exercise, on blood glucose levels and shares insights from his experiences with fasting and endurance challenges. We also touch on the significance of gut health and the role of infections in diabetes management, emphasising the need for quality information and community support for those living with diabetes.

In this conversation, Zoë Harcombe and Hannah Sutter discuss the complexities of the ketogenic diet, exploring its history, variants, and applications in both weight loss and medical treatment, particularly for epilepsy. They discuss personal experiences with keto, the importance of compliance, and the need for individualised dietary approaches. The conversation also touches on future research directions and the potential of keto in addressing various health issues.

In this episode, Zoë chats with Dr Benjamin Bikman about GLP-1 agonists, a class of drugs used for weight loss and diabetes management. They discuss the role of GLP-1 in metabolism, the effects of GLP-1 agonists on weight loss and insulin sensitivity, and the potential side effects and limitations of these drugs.

Dr Bikman explains how GLP-1 agonists slow down intestinal movement, leading to feelings of nausea and reduced appetite. He also discusses the paradox of these drugs stimulating the growth of new fat cells while promoting weight loss.

Full show notes and video over at https://www.zoeharcombe.com